Aristotle University Of Thessaloniki (AUTH)
Σύνθεση και μελέτη νέων πολυεστέρων γλυκερίνης με αλειφατικά οξέα και οργανομεταλλικών πλεγμάτων (MOFs) ως συστήματα στόχευσης και ελεγχόμενης αποδέσμευσης φαρμάκου
Abstract
dc:descriptionIn recent years, polymer science has made rapid progress in various fields, such as medicine, pharmaceuticals, tissue engineering, and industry. The demands of modern life have led scientists to discover new synthetic polymers without burdening environmental systems. For this reason, efforts have focused on inventing alternative methods that avoid the use of toxic catalysts. Synthetic aliphatic polyesters are widely used due to their high biodegradability and cost-effective production. Most biocompatible polymers used in medical devices or potentially applied in biomedical applications consist of substances that are natural metabolites, biocompatible, and non-toxic. Poly(ortho)esters are attractive due to their inherent hydrolytic instability; however, these functionally useful materials are difficult to produce because of the complexity of the required monomers. The appeal of this class of polymers lies in their vast diversity and synthetic versatility. Over the past three decades, chemists have focused on polyglycerol esters because of their ability to modify the pendant hydroxyl group in the polymer chain. Glycerol-based polyesters can exhibit properties similar to those of low-molecular-weight glycerides, but with the advantage of higher mechanical stability and longer in vivo circulation times. According to the U.S. Food and Drug Administration (FDA), succinic acid and glycerol are considered safe materials and have been approved for medical use. Both of these natural compounds are abundant, and their main advantage lies in their cost-effective production. The first part of this study concerns the synthesis and characterization of a new polyglycerol ester, PGSuc, at specific ratios and different temperatures. The synthesized oligoesters were studied in terms of their chemical and mechanical properties to evaluate and select the most suitable material. The selected PGSuc was used as a coating medium for 1393 Bioglass scaffolds to improve their mechanical properties and enhance their performance in terms of bioactivity, biocompatibility, and osteogenic differentiation of human adipose-derived mesenchymal stem cells (hAMSCs).The construction of composite polymer-ceramic scaffolds could offer a solution that combines the advantages of high porosity with improved mechanical strength. Meanwhile, other properties, such as antimicrobial or antibacterial effects, can also be tailored using polymeric materials. Mesoporous silica-based nanoparticles (MSNs) have emerged as a highly promising drug delivery system. Dexamethasone sodium phosphate (DexSP) is one of the most commonly used corticosteroid drugs for treating various dental conditions, such as reducing postoperative pain in patients who have had impacted third molars extracted. The aim of the present study is the synthesis of poly(glycerol succinate) (PGSuc) and the evaluation of its effectiveness as a coating material for 1393 bioactive glass scaffolds. Pure PGSuc, as well as DexSP-loaded PGSuc and PGSuc containing DexSP-loaded MSNs, were evaluated as different coating types for 1393 bioactive glass scaffolds. In the second part of this study, a new glycerol-based polyester, PGP, was synthesized in a similar manner. More specifically, newly synthesized oligoesters were prepared in different ratios and at various temperatures and were then processed to yield a rigid polymer. This final polymer is proposed as a potential additive for the treatment of dry eye syndrome. Chronic dry eye syndrome is a condition that affects a large number of individuals, and current treatments are mostly temporary. Lifitegrast is a drug administered in such cases in the form of eye drops. Due to the limitations of this method, our study proposes a more permanent solution involving the incorporation of the drug into PGP in the form of a contact lens. Slow and sustained release is the goal, which can be achieved either by directly embedding lifitegrast into PGP or by first adsorbing the drug into MOFs and then incorporating this system into the polymer.ZIF-8 metal–organic frameworks exhibit excellent properties, such as high stability, porosity, and biocompatibility, making them highly attractive for biomedical applications. In ophthalmic applications, ZIF-8 has been studied as a carrier for targeted drug delivery, mainly due to its ability to protect sensitive molecules from degradation and to allow for controlled release. In conclusion, the lifitegrast–PGP and lifitegrast-loaded MOF–PGP systems were evaluated as potential additives for the treatment of chronic dry eye syndrome.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2025
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Nakiou, Eirini
- Νακίου, Ειρήνη
Subjects
dc:subject × 16Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/59371